Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 104,263
  • Shares Outstanding, K 109,336
  • Annual Sales, $ 3,600 K
  • Annual Income, $ -266,580 K
  • 60-Month Beta 0.74
  • Price/Sales 4.53
  • Price/Cash Flow N/A
  • Price/Book 0.46
Trade BLUE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings $-0.66 on 11/07/23
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 122.90% ( -33.39%)
  • Historical Volatility 84.11%
  • IV Percentile 37%
  • IV Rank 29.49%
  • IV High 232.70% on 12/07/23
  • IV Low 76.97% on 10/16/23
  • Put/Call Vol Ratio 0.26
  • Today's Volume 836
  • Volume Avg (30-Day) 1,355
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 92,973
  • Open Int (30-Day) 103,461

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.47
  • Number of Estimates 6
  • High Estimate -0.29
  • Low Estimate -0.69
  • Prior Year 0.21
  • Growth Rate Est. (year over year) -323.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9200 +5.50%
on 04/18/24
1.4200 -31.65%
on 03/28/24
-0.3994 (-29.15%)
since 03/22/24
3-Month
0.8790 +10.42%
on 02/06/24
1.9200 -49.45%
on 02/27/24
-0.1994 (-17.04%)
since 01/23/24
52-Week
0.8790 +10.42%
on 02/06/24
5.5300 -82.45%
on 12/08/23
-2.4594 (-71.70%)
since 04/21/23

Most Recent Stories

More News
Is Bluebird Bio Stock a Buy?

This small biotech is struggling to fly -- and investors should probably steer clear.

BLUE : 0.9706 (+1.78%)
Better Buy: Bluebird Bio Vs. Novavax

Who wins this face-to-face between two beaten-down biotechs?

BLUE : 0.9706 (+1.78%)
NVAX : 4.19 (+2.95%)
Is This Beaten-Down Stock a Good Acquisition Target?

This company has proven its innovative abilities, but that's not enough to outperform the market.

BLUE : 0.9706 (+1.78%)
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst

Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.

WFC : 60.94 (-0.26%)
BLUE : 0.9706 (+1.78%)
Why Bluebird Bio Stock Flew Higher Than the Market Today

The company was thrown a financial lifeline.

HTGC : 18.85 (+0.86%)
BLUE : 0.9706 (+1.78%)
Is Bluebird Bio Stock a Buy Now?

Are you feeling brave?

BLUE : 0.9706 (+1.78%)
Why Bluebird Bio Stock Dived Into the Red on Tuesday

The biotech has had a tough time of it over the past few years; a pundit's revised take on the company won't improve that situation.

HSBC : 41.89 (+0.65%)
BLUE : 0.9706 (+1.78%)
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today

The answer hardly inspires confidence.

BLUE : 0.9706 (+1.78%)
2 Red Flags for Bluebird Bio Stock

The biotech's struggles may continue.

VRTX : 404.91 (+1.25%)
CRSP : 56.41 (+1.35%)
BLUE : 0.9706 (+1.78%)
Better Risky Investment: Bluebird Bio vs. Shiba Inu

Few investors dare to tread where the ice is known to be very thin.

CRSP : 56.41 (+1.35%)
BLUE : 0.9706 (+1.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic...

See More

Key Turning Points

3rd Resistance Point 1.1253
2nd Resistance Point 1.0877
1st Resistance Point 1.0291
Last Price 0.9706
1st Support Level 0.9329
2nd Support Level 0.8953
3rd Support Level 0.8367

See More

52-Week High 5.5300
Fibonacci 61.8% 3.7533
Fibonacci 50% 3.2045
Fibonacci 38.2% 2.6557
Last Price 0.9706
52-Week Low 0.8790

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar